From: Risk factors for endometrial carcinoma among postmenopausal women in Sri Lanka: a case control study
Characteristics | Disease Status | OR | 95% CI | p value | |||
---|---|---|---|---|---|---|---|
Cases (N = 83) | Controls (N = 332) | ||||||
n | % | n | % | ||||
Duration of Diabetes Mellitus | |||||||
≥ 5 years | 18 | 21.7 | 59 | 17.8 | 1.28 | 0.71–2.32 | p = 0.41 |
< 5 years | 65 | 78.3 | 273 | 82.2 | 1.0 | ||
Duration of Hypertension | |||||||
≥ 5 years | 25 | 30.1 | 62 | 18.7 | 1.88 | 1.10–3.23 | p = 0.02 |
< 5 years | 58 | 69.9 | 270 | 81.3 | 1.0 | ||
Duration of Hyperlipidemia | |||||||
≥ 5 years | 10 | 12.0 | 34 | 10.2 | 1.20 | 0.57–2.54 | p = 0.63 |
< 5 years | 73 | 88.0 | 298 | 89.8 | 1.0 | ||
On long term medication | |||||||
≥ 5 years | 34 | 41.0 | 102 | 30.7 | 1.56 | 0.95–2.56 | p = 0.07 |
< 5 years | 49 | 59.0 | 230 | 69.3 | 1.0 | ||
Tamoxifen | |||||||
Yes | 4 | 4.8 | 0 | 0.3 | 5.20 | 4.27–6.34 | p < 0.001 |
No | 79 | 95.2 | 332 | 99.7 | 1.0 | ||
Exposure to any x-ray | |||||||
Ever exposed | 63 | 75.9 | 185 | 55.7 | 2.50 | 1.45–4.33 | p < 0.001 |
Never exposed | 20 | 24.1 | 147 | 44.3 | 1.0 | ||
Fibroid | |||||||
Yes | 12 | 14.5 | 80 | 24.1 | 0.53 | 0.27–1.03 | p = 0.06 |
No | 71 | 85.5 | 252 | 75.9 | 1.0 | ||
Endometriosis | |||||||
Yes | 20 | 24.1 | 72 | 21.7 | 1.15 | 0.65–2.02 | p = 0.63 |
No | 63 | 75.9 | 260 | 78.3 | 1.0 | ||
Adenomyosis | |||||||
Yes | 8 | 9.6 | 74 | 22.3 | 0.37 | 0.17–0.81 | p = 0.01 |
No | 75 | 90.4 | 258 | 77.7 | 1.0 | ||
PID1 | |||||||
Yes | 4 | 4.8 | 14 | 4.2 | 1.15 | 0.37–3.59 | p = 0.81 |
No | 79 | 95.2 | 318 | 95.8 | 1.0 | ||
Vaginal Infection | |||||||
Yes | 9 | 10.8 | 36 | 10.5 | 1.03 | 0.47–2.24 | p = 0.93 |
No | 74 | 89.2 | 296 | 89.5 | 1.0 | ||
History of PCOD2 | |||||||
Yes | 8 | 9.6 | 17 | 5.1 | 1.98 | 0.82–4.75 | p = 0.12 |
No | 75 | 90.4 | 315 | 94.9 | 1.0 | ||
Family history of any type of cancer | |||||||
Yes | 31 | 37.3 | 19 | 5.7 | 9.82 | 5.17- | p < 0.001 |
No | 52 | 62.7 | 313 | 94.3 | 1.0 | 18.66 | |
Total | 83 | 100.0 | 332 | 100.0 |